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Background: Contrast-induced acute kidney injury is a significant cause of morbidity and mortality among hospitalized patients.
Although interventionists need to be aware of strategies to reduce the risk of acute kidney injury (AKI), there were no biological markers to more 
accurately predict the occurrence of AKI than the existing makers such as serum creatinine (sCr).
Liver-type fatty acid-binding protein (L-FABP) as a maker is an intracellular carrier protein of free fatty acids that marked upregulated and expressed 
abundantly in proximal tubules after renal ischemia. The present study was undertaken to examine whether L-FABP is a predictive marker for AKI and 
the long-term prognosis after coronary angiography.
Methods: We enrolled 130 patients undergoing scheduled coronary angiography with chronic kidney disease with sCr level greater than 1.3 mg/
dL(115micromol/l), treated with one-half isotonic saline between 12 hours before and after angiography.
We measured urinary L-FABP, u-Alb, `2-microglobulin, sCr and u-NAG. These samples were collected at the time of admission, then at 24 hours, 48 
hours. AKI was defined as an increase of 0.3 mg/dl (26.5micromol/l) within 2 days of contrast media exposure.
Results:  AKI occurred in 16 of 130 patients (12%). These makers levels (sCr, GFR, `2MG, u-NAG) at previous day are no significant differences 
between AKI group and Non-AKI group. However L-FABP and u-Alb level at previous day show significant change. Multivariate analysis revealed that 
L-FABP≥24.7 (μg/gCRE) (odds ratio: 7.83; P value: 0.018) were a significant predictor of AKI. The median duration of long-term follow-up was 633 
days (range 29 to 1255 days). Ten patients died during a follow-up period.
Kaplan-Meier analysis for long-term survival depending on the occurrence of AKI within 48 Hr suffered from markedly worse survival rate (P=0.0054 
log rank test)
In addition, L-FABP≥24.7μg/g Cre before angiography suffered from markedly worse survival rate (P=0.0067 log rank test) .
Conclusions: We conclude that urinary L-FABP has been clinically recognized as a useful biomarker for an early detection of kidney injury and 
long-term survival.
